Refractory Major Depression Disorder Rmdd clinical trials

Explore recruiting refractory major depression disorder rmdd clinical trials.

Also recruiting in Europe

Refractory Major Depression Disorder Rmdd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparison between esketamine nasal spray versus aripiprazole, both in combination with an antidepressant, in the refractory major depression disorder (RMDD) in elderly patients (CESAR)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Refractory Major Depression Disorder Rmdd trials by city

Refractory Major Depression Disorder Rmdd in Toronto Refractory Major Depression Disorder Rmdd in Vancouver Refractory Major Depression Disorder Rmdd in Montreal Refractory Major Depression Disorder Rmdd in Calgary Refractory Major Depression Disorder Rmdd in Edmonton Refractory Major Depression Disorder Rmdd in Ottawa Refractory Major Depression Disorder Rmdd in Winnipeg Refractory Major Depression Disorder Rmdd in Quebec City Refractory Major Depression Disorder Rmdd in Hamilton Refractory Major Depression Disorder Rmdd in Kitchener Refractory Major Depression Disorder Rmdd in London Refractory Major Depression Disorder Rmdd in Halifax Refractory Major Depression Disorder Rmdd in New York Refractory Major Depression Disorder Rmdd in Los Angeles Refractory Major Depression Disorder Rmdd in Chicago Refractory Major Depression Disorder Rmdd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease